HPV vaccination is associated with lower risk of cancers among female
- PMID: 41138956
- DOI: 10.1016/j.amjmed.2025.10.016
HPV vaccination is associated with lower risk of cancers among female
Abstract
Background: HPV vaccines prevent certain cancers, but the broader long-term effects are unclear. We assessed whether HPV vaccination is associated with cancer risk among females aged 9-26 years.
Methods: Retrospective cohort study in the TriNetX U.S. Collaborative Network (Jan 1, 2013-Dec 31, 2022) comparing HPV-vaccinated vs unvaccinated females after 1:1 PSM; Cox proportional-hazards models estimated HRs (95% CIs), with subgroup analyses by age, race/ethnicity, and vaccine valence, and sensitivity analyses using active comparators (influenza- and HBV-vaccinated) and a health check-up cohort.
Results: The findings showed that HPV vaccination was significantly associated with overall cancer risk (HR 0.38, 95% CI 0.34-0.42), with greater reduction when initiated at ages 9-14 vs 15-26 (HR 0.37 vs 0.54). Both 9vHPV and 4vHPV vaccines lowered cancer risks, with consistent support from sensitivity analyses.
Conclusions: In this multi-institutional retrospective cohort, HPV vaccination was associated with lower incidence of several cancers among females aged 9-26 years.
Keywords: HPV vaccination. cancers; cohort study;TriNetX.
Copyright © 2025. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest The authors declare no conflicts of interest: Yao-Min Hung; Ting-An Lin; Shiow-Ing Wang; Pei-Ju Wu; Renin Chang; James Cheng-Chung Wei.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
